CIK 0001816590 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in X0 · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Net income (USD) | -91.5 M | -60.3 M | ||
| Diluted EPS (USD/shares) | -3.08 | -2.32 | -2.16 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-10 | 144 | 144 | |
| 2026-08-07 | 144 | 144 | |
| 2026-08-05 | 4 | FORM 4 | 2026-08-03 |
| 2026-08-05 | S-3ASR | S-3ASR | |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-07 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-07-07 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-27 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-27 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-27 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-27 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-27 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-27 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-27 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-27 |
| 2026-05-29 | 3 | FORM 3 | 2026-05-27 |
| 2026-05-28 | 8-K | 8-K items 5.07 | 2026-05-27 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-13 | 8-K | 8-K items 2.02,9.01 | 2026-05-13 |
| 2026-05-13 | 10-Q | 10-Q | 2026-03-31 |
| 2026-04-15 | ARS | ARS | 2025-12-31 |
| 2026-04-15 | DEF 14A | DEF 14A | 2026-05-27 |
| 2026-03-27 | 4 | FORM 4 | 2026-03-26 |
| 2026-03-27 | 4 | FORM 4 | 2026-03-26 |
| 2026-03-27 | 4 | FORM 4 | 2026-03-26 |
Forms on file (last 1,000): 4 115, 8-K 48, 6-K 23, 3 21, 10-Q 14, SCHEDULE 13G/A 11, CORRESP 9, S-8 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CMPS (0.002 USD), /gw/filings/filings?ticker=CMPS&form=8-K, /gw/filings/facts?ticker=CMPS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange